Detalhe da pesquisa
1.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Br J Cancer
; 124(3): 587-594, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154570